Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in OTLK — Outlook Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in OTLK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,539,421
+$1,511,800 QoQ
Shares Held
968,190
+622.1% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 68 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OTLK Over Time

Shares Held

Position Value (USD)

Derivatives in OTLK

reported options exposure · as of Jun 30, 2026
CallValue
$862,098
CallShares
542,200
PutValue
$284,928
PutShares
179,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. OTLK ranks #98 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,539,421 968,190
2026-06-30 $284,928 179,200
2026-06-30 $862,098 542,200
2026-03-31 $27,621 134,084
2026-03-31 $8,816 42,800
2025-12-31 $304,782 192,900
2025-12-31 $271,794 172,022
2025-12-31 $581,124 367,800
2025-09-30 $25,970 24,500
2025-09-30 $224,106 211,421
2025-06-30 $188,430 117,769
2025-06-30 $26,880 16,800
2025-03-31 $21,228 17,400
2025-03-31 $86,524 70,922
2024-12-31 $153,609 81,275
2024-12-31 $40,068 21,200
2024-09-30 $225,348 42,200
2024-09-30 $60,876 11,400
2024-06-30 $115,703 15,678
2024-06-30 $96,678 13,100
2023-12-31 $20,990 53,276
2023-06-30 $94,339 54,218
2023-03-31 $96,348 88,393
2022-12-31 $23,220 21,500
2022-09-30 $43,802 35,904
2022-03-31 $32,782 18,417
2021-03-31 $373,128 165,835